The basal-like molecular subclass of human breast cancers is characterized by increased expression of HIF target genes and largely overlaps with the triple-negative clinical subclass of breast cancers that lack expression of the estrogen receptor, progesterone receptor, and HER2 [31]. The gene discussed is PGR; the disease is breast cancer.